{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:34:10Z","timestamp":1789932850991,"version":"4.0.1"},"reference-count":61,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,11]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>In sickle cell disease, ONFH incidence accelerates in early adulthood. Frequent hospitalizations and antecedent acute chest syndrome are independently associated with sickle cell\u2013related ONFH.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017005256","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T20:25:36Z","timestamp":1499804736000},"page":"1287-1295","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":81,"title":["Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California"],"prefix":"10.1182","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-9114","authenticated-orcid":false,"given":"Oyebimpe","family":"Adesina","sequence":"first","affiliation":[{"name":"Division of Hematology, Stanford University School of Medicine, Stanford, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Brunson","sequence":"additional","affiliation":[{"name":"Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa H. M.","family":"Keegan","sequence":"additional","affiliation":[{"name":"Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-7172","authenticated-orcid":false,"given":"Ted","family":"Wun","sequence":"additional","affiliation":[{"name":"Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"issue":"3","key":"2019111607585606900_B1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1302\/0301-620X.74B3.1587879","article-title":"Hip arthroplasty in patients with sickle-cell haemoglobinopathy","volume":"74","author":"Acurio","year":"1992","journal-title":"J Bone Joint Surg Br"},{"issue":"2","key":"2019111607585606900_B2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5581\/1516-8484.20120036","article-title":"Osteoarticular involvement in sickle cell disease","volume":"34","author":"da Silva Junior","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"2","key":"2019111607585606900_B3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2106\/JBJS.J.00919","article-title":"The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease","volume":"94","author":"Poignard","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"2019111607585606900_B4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874325000903010032","article-title":"Multifocal joint osteonecrosis in sickle cell disease","volume":"3","author":"Flouzat-Lachaniete","year":"2009","journal-title":"Open Orthop J"},{"issue":"1","key":"2019111607585606900_B5","first-page":"23","article-title":"Imaging of avascular necrosis of femoral head: familiar methods and newer trends","volume":"35","author":"Stoica","year":"2009","journal-title":"Curr Health Sci J"},{"issue":"2","key":"2019111607585606900_B6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5604\/15093492.992286","article-title":"Avascular necrosis of the femoral head in sickle cell disease patients","volume":"14","author":"Matos","year":"2012","journal-title":"Ortop Traumatol Rehabil"},{"issue":"1","key":"2019111607585606900_B7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000046529","article-title":"Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait","volume":"105","author":"Adekile","year":"2001","journal-title":"Acta Haematol"},{"issue":"23","key":"2019111607585606900_B8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111607585606900_B9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2106\/00004623-200303000-00016","article-title":"The natural history of symptomatic osteonecrosis in adults with sickle-cell disease","volume":"85-A","author":"Hernigou","year":"2003","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"2019111607585606900_B10","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2106\/JBJS.E.01455","article-title":"The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease","volume":"88","author":"Hernigou","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2019111607585606900_B11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.hoc.2005.07.001","article-title":"Bone and joint disease in sickle cell disease","volume":"19","author":"Aguilar","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"2019111607585606900_B12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.arth.2011.04.042","article-title":"Modern total hip arthroplasty in patients younger than 21 years","volume":"27","author":"Kamath","year":"2012","journal-title":"J Arthroplasty"},{"issue":"10","key":"2019111607585606900_B13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"2019111607585606900_B14","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V126.23.2069.2069","article-title":"A systematic review of the classification, diagnosis, treatment and outcome of osteonecrosis of the hips in sickle cell disease","volume":"126","author":"Mullah-Ali","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019111607585606900_B15","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2106\/00004623-200612000-00003","article-title":"Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment","volume":"88","author":"Neumayr","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"21","key":"2019111607585606900_B16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111607585606900_B17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.med.0000436192.25846.0b","article-title":"An update on the recent literature on sickle cell bone disease","volume":"20","author":"Osunkwo","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"2019111607585606900_B18","first-page":"125","article-title":"The role of osteotomy in advanced osteonecrosis of the femoral head in sickle-cell disease: a case report","volume":"35","author":"Patel","year":"2006","journal-title":"Am J Orthop"},{"issue":"4","key":"2019111607585606900_B19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002640050068","article-title":"Bipolar hip replacement in sickle cell disease","volume":"20","author":"Sanjay","year":"1996","journal-title":"Int Orthop"},{"issue":"2","key":"2019111607585606900_B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<103::AID-AJH6>3.0.CO;2-Y","article-title":"Core decompression in avascular necrosis of the hip in sickle-cell disease","volume":"52","author":"Styles","year":"1996","journal-title":"Am J Hematol"},{"issue":"7","key":"2019111607585606900_B21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-12-4973","article-title":"Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study","volume":"106","author":"Hankins","year":"2005","journal-title":"Blood"},{"issue":"17","key":"2019111607585606900_B22","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"10019","key":"2019111607585606900_B23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"2019111607585606900_B24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/003335491312800206","article-title":"Mortality rates and age at death from sickle cell disease: U.S., 1979-2005","volume":"128","author":"Lanzkron","year":"2013","journal-title":"Public Health Rep"},{"issue":"5","key":"2019111607585606900_B25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amepre.2014.07.025","article-title":"Public health surveillance of nonmalignant blood disorders","volume":"47","author":"Beckman","year":"2014","journal-title":"Am J Prev Med"},{"issue":"2","key":"2019111607585606900_B26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/003335491613100221","article-title":"Defining sickle cell disease mortality using a population-based surveillance system, 2004 through 2008","volume":"131","author":"Paulukonis","year":"2016","journal-title":"Public Health Rep"},{"issue":"12","key":"2019111607585606900_B27","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/pbc.25208","article-title":"Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)","volume":"61","author":"Paulukonis","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2019111607585606900_B28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/pbc.22792","article-title":"Sickle-cell disease in California: a population-based description of emergency department utilization","volume":"56","author":"Wolfson","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111607585606900_B29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pbc.22979","article-title":"Sickle cell disease in California: sociodemographic predictors of emergency department utilization","volume":"58","author":"Wolfson","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"289","key":"2019111607585606900_B30","first-page":"136","article-title":"Osteonecrosis of the humeral head in sickle cell disease","author":"Milner","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"2019111607585606900_B31","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality [published online ahead of print 3 April 2017]","author":"Brunson","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111607585606900_B32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"issue":"20","key":"2019111607585606900_B33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111607585606900_B34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00062752-199803000-00002","article-title":"Acute chest syndrome and sickle cell disease","volume":"5","author":"Golden","year":"1998","journal-title":"Curr Opin Hematol"},{"issue":"25","key":"2019111607585606900_B35","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111607585606900_B36","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V89.5.1787","article-title":"Acute chest syndrome in sickle cell disease: clinical presentation and course","volume":"89","author":"Vichinsky","year":"1997","journal-title":"Blood"},{"issue":"7","key":"2019111607585606900_B37","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","article-title":"A note on competing risks in survival data analysis","volume":"91","author":"Satagopan","year":"2004","journal-title":"Br J Cancer"},{"issue":"10","key":"2019111607585606900_B38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4103\/0019-5049.167490","article-title":"Avascular necrosis of left hip joint secondary to sickle cell anaemia for hip arthroplasty","volume":"59","author":"Borkar","year":"2015","journal-title":"Indian J Anaesth"},{"issue":"8","key":"2019111607585606900_B39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.otsr.2011.09.011","article-title":"Risk factors and impact of orthopaedic monitoring on the outcome of avascular necrosis of the femoral head in adults with sickle cell disease: 215 patients case study with control group","volume":"97","author":"Mukisi-Mukaza","year":"2011","journal-title":"Orthop Traumatol Surg Res"},{"issue":"2","key":"2019111607585606900_B40","first-page":"89","article-title":"[Avascular necrosis of the femoral head in children with sickle cell disease (Libreville, Gabon)]","volume":"21","author":"Mouba","year":"2011","journal-title":"Sante"},{"issue":"9","key":"2019111607585606900_B41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.22103","article-title":"Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease","volume":"86","author":"Mahadeo","year":"2011","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111607585606900_B42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11999-007-0069-3","article-title":"Total THA in adult osteonecrosis related to sickle cell disease","volume":"466","author":"Hernigou","year":"2008","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2019111607585606900_B43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/1117-1936.180339","article-title":"Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study","volume":"14","author":"Akinyoola","year":"2007","journal-title":"Niger Postgrad Med J"},{"issue":"2","key":"2019111607585606900_B44","first-page":"53","article-title":"A method to identify California\u2019s sickle-cell disease population and its linkage to the California Cancer Registry","volume":"39","author":"Brown","year":"2012","journal-title":"J Registry Manag"},{"issue":"2","key":"2019111607585606900_B45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/gim.2014.81","article-title":"State-based surveillance for selected hemoglobinopathies","volume":"17","author":"Hulihan","year":"2015","journal-title":"Genet Med"},{"issue":"4 Suppl","key":"2019111607585606900_B46","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"31","key":"2019111607585606900_B47","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2011.37.3217","article-title":"Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia","volume":"29","author":"te Winkel","year":"2011","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111607585606900_B48","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2007.14.9088","article-title":"Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"26","author":"Kadan-Lottick","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111607585606900_B49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.14423\/SMJ.0000000000000512","article-title":"Symptomatic avascular necrosis: an understudied risk factor for acute care utilization by patients with SCD","volume":"109","author":"Yu","year":"2016","journal-title":"South Med J"},{"issue":"1","key":"2019111607585606900_B50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"issue":"13","key":"2019111607585606900_B51","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"9870","key":"2019111607585606900_B52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"2019111607585606900_B53","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamasurg.2015.1239","article-title":"Comparison of US and Canadian perioperative outcomes and hospital efficiency after total hip and knee arthroplasty","volume":"150","author":"Hart","year":"2015","journal-title":"JAMA Surg"},{"issue":"1","key":"2019111607585606900_B54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2010.03.009","article-title":"Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States","volume":"126","author":"White","year":"2010","journal-title":"Thromb Res"},{"issue":"10","key":"2019111607585606900_B55","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","article-title":"Survival in adults with sickle cell disease in a high-income setting","volume":"128","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2019111607585606900_B56","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"issue":"20","key":"2019111607585606900_B57","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2015-04-641969","article-title":"Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease","volume":"126","author":"Dalle Carbonare","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111607585606900_B58","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.arth.2010.11.010","article-title":"Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years","volume":"26","author":"Agarwala","year":"2011","journal-title":"J Arthroplasty"},{"issue":"6","key":"2019111607585606900_B59","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10067-008-0861-9","article-title":"The use of bisphosphonate in the treatment of avascular necrosis: a systematic review","volume":"27","author":"Cardozo","year":"2008","journal-title":"Clin Rheumatol"},{"key":"2019111607585606900_B60","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.12659\/MSM.891123","article-title":"Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review","volume":"20","author":"Luo","year":"2014","journal-title":"Med Sci Monit"},{"issue":"8","key":"2019111607585606900_B61","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2106\/00004623-200708000-00009","article-title":"Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents","volume":"89","author":"Ramachandran","year":"2007","journal-title":"J Bone Joint Surg Am"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/16\/1287\/877498\/advances005256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/16\/1287\/877498\/advances005256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T08:09:30Z","timestamp":1692864570000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/16\/1287\/15630\/Osteonecrosis-of-the-femoral-head-in-sickle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":61,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,7,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017005256","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]}}}